Cite
Fibroblast growth factor 23 as a predictor of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation and various risk of stroke
MLA
T. P. Gizatulina, et al. “Fibroblast Growth Factor 23 as a Predictor of Left Atrial Appendage Thrombosis in Patients with Nonvalvular Atrial Fibrillation and Various Risk of Stroke.” Journal of Arrhythmology, vol. 29, Dec. 2022, pp. 33–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c002acfa79535f8cc12934a7764855a9&authtype=sso&custid=ns315887.
APA
T. P. Gizatulina, N. Yu. Khorkova, E. A. Gorbatenko, A. V. Mamarina, T. I. Petelina, & L. U. Martyanova. (2022). Fibroblast growth factor 23 as a predictor of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation and various risk of stroke. Journal of Arrhythmology, 29, 33–41.
Chicago
T. P. Gizatulina, N. Yu. Khorkova, E. A. Gorbatenko, A. V. Mamarina, T. I. Petelina, and L. U. Martyanova. 2022. “Fibroblast Growth Factor 23 as a Predictor of Left Atrial Appendage Thrombosis in Patients with Nonvalvular Atrial Fibrillation and Various Risk of Stroke.” Journal of Arrhythmology 29 (December): 33–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c002acfa79535f8cc12934a7764855a9&authtype=sso&custid=ns315887.